FDAnews
www.fdanews.com/articles/145927-new-j-amp-j-ceo-zeroes-in-on-recalls

New J&J CEO Zeroes in on Recalls

April 26, 2012
Alex Gorsky, Johnson & Johnson’s incoming chief executive, said his no. 1 priority is fixing the problems in the company’s OTC medicine business following recent recalls that have dimmed sales and damaged the health-care giant’s reputation.
The Wall Street Journal